Síntese, caracterização e avaliação biológica de compostos heterocíclicos
Loading...
Date
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Universidade Federal de Juiz de Fora (UFJF)
DOI
Abstract
The present work describes the synthesis, characterization and in vitro
biological evaluation of molecular hybrid compounds. The first part involved
molecular docking, where molecular hybrids, derivatives of 4-aminoquinoline and
sulfonamides were highlighted in a screening carried out with more than 150
compounds synthesized by the research group against the inhibition of the replication
of the SARS-CoV-2 virus and in the inhibition of the acetylcholinesterase, βsecretase and glycogen synthase kinase 3β enzymes, related to Alzheimer's disease
(AD). The assays involving the inhibition of replication of the SARS-CoV-2 virus
showed promising results, as the inhibition exceeded 95% for some of the
compounds, at a concentration of 10 µM. Regarding the biological tests involving ADrelated enzymes, compound 8 showed high inhibition in the three enzymes and
became a promising multi-target enzymatic inhibitor in the treatment of this disease.
The second part involves molecular hybrid compounds derived from alkylated 1,2,3-
triazoles with acridine or purine, as well as their in vitro antileishmanial evaluation.
Description
Keywords
COVID-19 , Alzheimer , Leishmaniose , 1,2,3-triazol , Quinolina , Sulfonamidas , Acridina , Purina , Leishmaniasis , 1,2,3-triazole , Quinoline , Sulphonamide , Acridine , Purine
Citation
Collections
Endorsement
Review
Supplemented By
Referenced By
Creative Commons license
Except where otherwise noted, this item's license is described as Acesso Aberto

